- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 114,300 | 09.08.24 20:48:35 | +0,380 | +0,33% | 114,290 | 114,310 | 112,920 | 113,920 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 100,160 | 09.08.24 20:46:30 | +3,240 | +3,34% | 99,840 | 100,500 | 97,330 | 96,920 |
